资讯

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...
These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs ... of Washington in Seattle. Trials show that drugs such as semaglutide ...
During this evolution, consumers are now familiar with Semaglutide products that have promising goals of weight loss. Ozempic, which is made from the drug Semaglutide and was initially developed ...
The weight loss can also lighten the load on hips and knees, and the drugs may help protect kidneys, too. What older adults should watch out for At the same time, doctors say there are issues that ...
The demand for highly sought-after weight-loss drugs continues to rise ... He added that there are also "emerging concerns about potential suicidal ideation, which is not yet proven but highlights ...
Diabetes and obesity are themselves serious medical conditions, but there are direct safety concerns ... loss. Considering the tendency toward rapid weight gain when these expensive drugs are ...
SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, public reception, and what lies ahead for pharmacotherapy in obesity ...
The FBI says counterfeit versions of the drugs can cause health issues. The FBI is warning the public about counterfeit compounded weight loss drugs on the market that claim to contain semaglutide ...
The popularity of newer weight-loss drugs that shed pounds quickly has raised concerns among researchers about how this will affect the health of our muscles, which do more than just give us strength.
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs, like Wegovy, have been approved for kids 12 and up and the number of ...
Israeli startup ProFuse Technology has launched a new drug discovery platform that seeks to prevent muscle mass loss caused by aging, cancer and the growing use of glucagon-like peptide-1 (GLP-1) ...